HOME › DRUGS › SIBEPRENLIMAB-SZSI
ACTIVE SUBSTANCE / INN

SIBEPRENLIMAB-SZSI

Brand name(s): VOYXACT
FDA LISTED
PRESCRIPTION
BLA761434
ACTIVE SUBSTANCE
Sibeprenlimab-Szsi
REGULATORS
FDA
SPONSORS / MAH
OTSUKA PHARM CO LTD
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
VOYXACTBLA761434OTSUKA PHARM CO LTDPrescription

FULL INTELLIGENCE ON SIBEPRENLIMAB-SZSI

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →